Abingworth Clinical Co-Development Co-Investment Fund, L.P. — Form D/A
Abingworth Clinical Co-Development Co-Investment Fund, L.P. of WASHINGTON, DC, a pooled investment fund, filed a Form D amendment with the SEC on 2023-11-17. $346.4M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2023-11-17
- Form: D/A
- Accession: 0001986436-23-000002
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Amount sold: $346.4M
- Investors: 18
- Date of first sale: 2023-08-25
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-490264
Issuer
- Name: Abingworth Clinical Co-Development Co-Investment Fund, L.P.
- CIK: 0001986436
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 1001 PENNSYLVANIA AVENUE, NW, WASHINGTON, DC, 20004
- Phone: 202-729-5626
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Jeremy Anderson | Executive Officer | Washington, DC |
| Christina Gibbs | Executive Officer | Washington, DC |
| Elizabeth Muscarella | Executive Officer | New York, NY |
| N/A CCD-CIF General Partner, L.P. | Promoter | Washington, DC |
| N/A CCD-CIF, L.L.C. | Promoter | Washington, DC |
Other filings by this issuer (1)
More